Abbott Gets First Monkeypox Test EUA For Commercial Use

The US Food and Drug Administration has granted Abbott emergency use authorization for its monkeypox test, making it the first diagnostic to detect the virus to become commercially available.

Monkeypox Test
• Source: Shutterstock

The US FDA has issued its first emergency use authorization (EUA) for a commercial monkeypox diagnostic to Abbott Molecular for its Alinity m MPXV real-time polymerase chain reaction (PCR) test that uses a lesion swab to detect the virus.

Though the FDA granted an EUA to Quest Diagnostics for its monkeypox PCR test in September, it was not for...

More from Regulation

More from Policy & Regulation